Streptococcus pyogenes polypeptides and corresponding DNA fragments

Details for Australian Patent Application No. 2002234455 (hide)

Owner ID Biomedical Corporation

Inventors Rioux, Stephane; Hamel, Josee; Martin, Denis; Brodeur, Bernard R.; Rheault, Patrick

Agent Davies Collison Cave

Pub. Number AU-B-2002234455

PCT Pub. Number WO2002/066650

Priority 60/269,840 21.02.01 US

Filing date 21 February 2002

Wipo publication date 4 September 2002

Acceptance publication date 17 January 2008

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 11/04 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/315 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

27 February 2003 Application Open to Public Inspection

  Published as AU-B-2002234455

1 September 2005 Assignment before Grant

  Shire Biochem Inc. The application has been assigned to ID Biomedical Corporation

17 January 2008 Application Accepted

  Published as AU-B-2002234455

3 April 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 30 Jan 2008. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000

15 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002234456-ENHANCED PICKUP-ELECTRODE

2002234454-WASTEWATER TREATMENT SYSTEM